Loading provider…
Loading provider…
Interventional Cardiology Physician in Oklahoma City, OK
NPI: 1073654893Primary Practice Location
OKLAHOMA HEART HOSPITAL, LLC
4050 W Memorial Rd, Oklahoma City, OK
Primary Employer
Ohh Physicians
okheart.com
HQ Phone
Get MD Beau's Phone Numberphone_androidMobile
Get MD Beau's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOK State Medical License

American Board of Internal Medicine
Cardiovascular Disease

American Board of Internal Medicine
Interventional Cardiology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 898 | 1,084 |
| 2 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 454 | 460 |
| 3 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 201 | 211 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 182 | 182 |
| 5 | 99152Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | 146 | 170 |
Coronary slow flow--prevalence and clinical correlations.
Authors: Talla Rousan, Eliot Schechter, Stavros Stavrakis, Mazen Abu-Fadel
Publication Date: 2012-02-02
A young patient with concurrent splanchnic dynamic vascular compression syndromes.
Authors: Joshua Gierman
Publication Date: 2015-04-17
Transradial access for carotid stenting: exceptional outcomes in experienced hands… will the results be generalizable?
Authors: Beau Hawkins, Douglas Drachman
Publication Date: 2012-10-14
Lead Sponsor: Hemostemix
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: ACP-01
Lead Sponsor: Carelon Research
Collaborators: Society for Vascular Surgery, National Heart, Lung, and Blood Institute (NHLBI), Massachusetts General Hospital, Brigham and Women's Hospital, Abbott Medical Devices, Boston Scientific Corporation, Abbott, Boston Medical Center, Bard Ltd, Cordis Corporation, Canadian Society for Vascular Surgery, Eastern Vascular Society, W.L.Gore & Associates, Midwest Vascular Society, New England Society for Vascular Surgery, Society for Clinical Vascular Surgery, Society for Interventional Radiology, Southern Vascular Society, Society for Vascular Medicine, Vascular and Endovascular Surgery Society, Vascular Interventional Advances, Western Vascular Society
Intervention / Treatment: PROCEDURE: Open surgical revascularization, DEVICE: Endovascular revascularization